[{"address1": "1199 West Hasting Street", "address2": "Suite 1400", "city": "Vancouver", "state": "BC", "zip": "V6E 3T5", "country": "Canada", "phone": "949-505-5623", "website": "https://www.lobesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lobe Sciences Ltd., a biopharmaceutical company, focuses on the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Frederick Dominick Sancilio M.S., Ph.D.", "age": 73, "title": "Chairman & CEO", "yearBorn": 1950, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Maghsoud  Dariani", "age": 68, "title": "Chief Science Officer", "yearBorn": 1955, "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0149, "open": 0.0149, "dayLow": 0.0149, "dayHigh": 0.0149, "regularMarketPreviousClose": 0.0149, "regularMarketOpen": 0.0149, "regularMarketDayLow": 0.0149, "regularMarketDayHigh": 0.0149, "beta": 2.286, "volume": 8500, "regularMarketVolume": 8500, "averageVolume": 48073, "averageVolume10days": 76390, "averageDailyVolume10Day": 76390, "bid": 0.012, "ask": 0.015, "marketCap": 253748, "fiftyTwoWeekLow": 0.0008, "fiftyTwoWeekHigh": 0.018, "priceToSalesTrailing12Months": 0.259791, "fiftyDayAverage": 0.001956, "twoHundredDayAverage": 0.002262, "currency": "USD", "enterpriseValue": 4488894, "floatShares": 82537705, "sharesOutstanding": 171560000, "heldPercentInsiders": 0.50992, "impliedSharesOutstanding": 181248992, "bookValue": -0.006, "lastFiscalYearEnd": 1693440000, "nextFiscalYearEnd": 1725062400, "mostRecentQuarter": 1717113600, "netIncomeToCommon": -2966143, "trailingEps": -0.02, "enterpriseToRevenue": 4.596, "enterpriseToEbitda": -1.654, "52WeekChange": -0.0714286, "SandP52WeekChange": 0.31426477, "exchange": "OQB", "quoteType": "EQUITY", "symbol": "LOBEF", "underlyingSymbol": "LOBEF", "shortName": "LOBE SCIENCES LTD.", "longName": "Lobe Sciences Ltd.", "firstTradeDateEpochUtc": 1692883800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "bb19c3da-b033-3774-9869-410506c32a2c", "messageBoardId": "finmb_569918770", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.0014, "recommendationKey": "none", "totalCash": 40992, "ebitda": -2713827, "totalDebt": 2213821, "quickRatio": 0.044, "currentRatio": 0.057, "totalRevenue": 976739, "revenuePerShare": 0.008, "returnOnAssets": -0.62089, "returnOnEquity": -48.33765, "freeCashflow": -2700250, "operatingCashflow": -1073419, "grossMargins": 0.97362, "ebitdaMargins": -2.77846, "operatingMargins": -2.89036, "financialCurrency": "CAD", "trailingPegRatio": null, "__fetch_time": "2024-12-07"}]